» Articles » PMID: 26979643

Regulatory Effect of Paraprobiotic Lactobacillus Gasseri CP2305 on Gut Environment and Function

Overview
Date 2016 Mar 17
PMID 26979643
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lactobacillus gasseri CP2305 (CP2305) is a strain of Lactobacillus isolated from a stool sample from a healthy adult that showed beneficial effects on health as a paraprobiotic. In a previous study, we demonstrated that CP2305-fermented heat-treated milk modified gut functions more than artificially acidified sour milk. Thus, the regulatory activity of the former beverage was attributed to the inactivated CP2305 cells.

Objective: The aim of this study was to elucidate the contribution of non-viable paraprobiotic CP2305 cells to regulating human gut functions. We thus conducted a randomized, placebo-controlled, double-blinded parallel group trial.

Design: The trial included 118 healthy participants with relatively low or high stool frequencies. The test beverage was prepared by adding 1×10(10) washed, heat-treated, and dried CP2305 cells directly to the placebo beverage. The participants ingested a bottle of the assigned beverage daily for 3 weeks and answered daily questionnaires about defecation and quality of life. Fecal samples were collected and the fecal characteristics, microbial metabolite contents of the feces and composition of fecal microbiota were evaluated.

Results: The number of evacuations and the scores for fecal odors were significantly improved in the group that consumed the CP2305-containing beverage compared with those of the group that consumed the placebo (p=0.035 and p=0.040, respectively). Regarding the fecal contents of microbial metabolites, the level of fecal p-cresol was significantly decreased in the CP2305 group relative to that of the placebo group (p=0.013). The Bifidobacterium content of the intestinal microbiota was significantly increased in the CP2305 group relative to that of the placebo group (p<0.008), whereas the content of Clostridium cluster IV was significantly decreased (p<0.003). The parasympathetic nerve activity of the autonomic nervous system became dominant and the total power of autonomic activity was elevated in the CP2305 group (p=0.0401 and p=0.011, respectively).

Conclusions: The continuous ingestion of heat-treated CP2305 cells clearly affected intestinal functionality. This is the first report of sterilized Lactobacillus cells having a significant impact on the environment and functions of the intestinal tract. The observed effects might be due, at least in part, to the brain-gut interaction.

Citing Articles

Additive effect of mixtures of multiple strains combining the effects of single strains on human gut microbiota .

Tsujikawa Y, Yamamoto J, Fukuda I, Sakane I Biosci Microbiota Food Health. 2025; 44(1):58-69.

PMID: 39764492 PMC: 11700551. DOI: 10.12938/bmfh.2024-059.


Saccharomyces yeast postbiotics mitigate mucosal damages from F18 Escherichia coli challenges by positively balancing the mucosal microbiota in the jejunum of young pigs.

Gormley A, Duarte M, Deng Z, Kim S Anim Microbiome. 2024; 6(1):73.

PMID: 39707576 PMC: 11662450. DOI: 10.1186/s42523-024-00363-y.


Gut microbiota microbial metabolites in diabetic nephropathy patients: far to go.

Yu J, Chen X, Zang S, Chen X, Wu Y, Wu L Front Cell Infect Microbiol. 2024; 14:1359432.

PMID: 38779567 PMC: 11109448. DOI: 10.3389/fcimb.2024.1359432.


It's Dead! Can Postbiotics Really Help Performance and Recovery? A Systematic Review.

Kerksick C, Moon J, Jager R Nutrients. 2024; 16(5).

PMID: 38474848 PMC: 10933997. DOI: 10.3390/nu16050720.


Saccharomyces cerevisiae derived postbiotic alters gut microbiome metabolism in the human distal colon resulting in immunomodulatory potential .

Duysburgh C, Miclotte L, Green J, Watts K, Sardi M, Chakrabarti A Front Microbiol. 2024; 15:1358456.

PMID: 38410391 PMC: 10895063. DOI: 10.3389/fmicb.2024.1358456.


References
1.
. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996; 17(3):354-81. View

2.
Shimizu K, Ogura H, Asahara T, Nomoto K, Morotomi M, Tasaki O . Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective. Dig Dis Sci. 2012; 58(1):23-32. PMC: 3557374. DOI: 10.1007/s10620-012-2334-x. View

3.
Kawakami K, Kojima K, Makino I, Kato I, Onoue M . Fasting enhances p-Cresol production in the rat intestinal tract. Exp Anim. 2007; 56(4):301-7. DOI: 10.1538/expanim.56.301. View

4.
Minami J, Kondo S, Yanagisawa N, Odamaki T, Xiao J, Abe F . Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial. J Nutr Sci. 2015; 4:e17. PMC: 4463018. DOI: 10.1017/jns.2015.5. View

5.
Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A . Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol. 2004; 97(6):1166-77. DOI: 10.1111/j.1365-2672.2004.02409.x. View